z-logo
open-access-imgOpen Access
The Effects of Nafamostat Mesilate on a Bleeding Risk as an Anticoagulant During Use as a Continuous Renal Replacement Therapy: Systematic Review
Author(s) -
강혜영,
강영주,
문수지
Publication year - 2018
Publication title -
the journal of health technology assessment
Language(s) - English
Resource type - Journals
ISSN - 2288-5811
DOI - 10.34161/johta.2018.6.2.008
Subject(s) - medicine , anticoagulant therapy , anticoagulant , intensive care medicine , renal replacement therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom